Literature DB >> 16007245

Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease.

Anne Moscona1.   

Abstract

Human parainfluenza viruses cause several serious respiratory diseases in children for which there is no effective prevention or therapy. Parainfluenza viruses initiate infection by binding to cell surface receptors and then, via coordinated action of the 2 viral surface glycoproteins, fuse directly with the cell membrane to release the viral replication machinery into the host cell's cytoplasm. During this process, the receptor-binding molecule must trigger the viral fusion protein to mediate fusion and entry of the virus into a cell. This review explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor-binding molecule triggers the fusion process. There are several steps during the process of binding, triggering, and fusion that are now understood at the molecular level, and each of these steps represents potential targets for interrupting infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007245      PMCID: PMC1159152          DOI: 10.1172/JCI25669

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  86 in total

Review 1.  Control of pediatric viral diseases: past successes and future prospects.

Authors:  R M Chanock
Journal:  Pediatr Res       Date:  1990-06       Impact factor: 3.756

2.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 3.  Virus-cell and cell-cell fusion.

Authors:  L D Hernandez; L R Hoffman; T G Wolfsberg; J M White
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

4.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

5.  The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.

Authors:  T Sergel; L W McGinnes; M E Peeples; T G Morrison
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

6.  Rational design of potent sialidase-based inhibitors of influenza virus replication.

Authors:  M von Itzstein; W Y Wu; G B Kok; M S Pegg; J C Dyason; B Jin; T Van Phan; M L Smythe; H F White; S W Oliver
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

7.  Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.

Authors:  D D Porter; G A Prince; V G Hemming; H G Porter
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.

Authors:  A Moscona; R W Peluso
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.

Authors:  X L Hu; R Ray; R W Compans
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  61 in total

1.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.

Authors:  Matteo Porotto; Micaela Fornabaio; Olga Greengard; Matthew T Murrell; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.

Authors:  Matteo Porotto; Micaela Fornabaio; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  Characterizing the Cellular Immune Response to Parainfluenza Virus 3.

Authors:  Paibel I Aguayo-Hiraldo; Reuben J Arasaratnam; Ifigeneia Tzannou; Manik Kuvalekar; Premal Lulla; Swati Naik; Caridad A Martinez; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

7.  Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery.

Authors:  Shohreh F Farzan; Laura M Palermo; Christine C Yokoyama; Gianmarco Orefice; Micaela Fornabaio; Aurijit Sarkar; Glen E Kellogg; Olga Greengard; Matteo Porotto; Anne Moscona
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

8.  Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.

Authors:  Christine A Baumann; Wolfgang J Neubert
Journal:  Arch Virol       Date:  2009-12-19       Impact factor: 2.574

9.  Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes.

Authors:  Lauren P McLaughlin; Haili Lang; Elizabeth Williams; Kaylor E Wright; Allison Powell; Conrad R Cruz; Anamaris M Colberg-Poley; Cecilia Barese; Patrick J Hanley; Catherine M Bollard; Michael D Keller
Journal:  Cytotherapy       Date:  2016-09-28       Impact factor: 5.414

10.  Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.

Authors:  Laura E Luque; Olga A Bridges; John N Mason; Kelli L Boyd; Allen Portner; Charles J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.